Hartfalen: epidemiologie, risicofactoren en toekomst

RIVM Rapport 260401006
Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D (1993). Survival after
the onset of congestive heart failure in Framingham Heart Study subjects.
Circulation 88, 107-15.
Hobbs FD, Jones MI, Allan TF, Wilson S, Tobias R (2000). European survey of
primary care physician perceptions on heart failure diagnosis and
management (Euro-HF). Eur Heart J 21, 1877-87.
Hobbs FD, Davis RC, Roalfe AK, Hare R, Davies MK, Kenkre JE (2002). Reliability
of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure:
cohort study in representative and high risk community populations. BMJ
324, 1498.
Hoes AW, Mosterd A (2007). Epidemiologie: prevalentie, incidentie en prognose.
In: A.A.Voors, J.H.Kirkels (red.). Leerboek hartfalen. Tweede editie. Houten:
Bohn, Stafleu, Van Loghem, 2007.
Hogg K, Swedberg K, Mcmurray J (2004). Heart failure with preserved left
ventricular systolic function; epidemiology, clinical characteristics, and
prognosis. J Am Coll Cardiol 43, 317-27.
Hoogenveen RT, van Baal PH, Boshuizen HC (2010). Chronic disease projections
in heterogeneous ageing populations: approximating Multi-state models of
joint distributions by modeling marginal distributions. Math Med Biol
2010;27:1-19.
Horio T, Kamide K, Takiuchi S, Yoshii M, Miwa Y, Matayoshi T, Yoshihara F,
Nakamura S, Tokudome T, Miyata T, Kawano Y (2010). Association of insulinlike
growth factor-1 receptor gene polymorphisms with left ventricular mass
and geometry in essential hypertension. J Hum Hypertens 24, 320-6.
Horwich TB, Fonarow GC (2010). Glucose, obesity, metabolic syndrome, and
diabetes. Relevance to incidence of heart failure. J Am Coll Cardiol 55: 283-
93.
Hunt SA. (2005). ACC/AHA 2005 guideline update for the diagnosis and
management of chronic heart failure in the adult: a report of the American
College of Cardiology/American Heart Association Task Force on Practice
Guidelines (Writing Committee to Update the 2001 Guidelines for the
Evaluation and Management of Heart Failure). J Am Coll Cardiol 46(6): e1-
82.
Ingelsson E, Arnlov J, Sundstrom J, Zethelius B, Vessby B, Lind L (2005). Novel
metabolic risk factors for heart failure. J Am Coll Cardiol 46, 2054-60.
Ingelsson E, Arnlov J, Lind L, Sundstrom J (2006). Metabolic syndrome and risk
for heart failure in middle-aged men. Heart 92, 1409-13.
Ippisch HM, Inge TH, Daniels SR, Wang B, Khoury PR, Witt SA, Glascock BJ,
Garcia VF, Kimball TR (2008). Reversibility of cardiac abnormalities in
morbidly obese adolescents. J Am Coll Cardiol 51, 1342-8.
Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW,
Tornos P, Vanoverschelde JL, Vermeer F, Boersma E, Ravaud P, Vahanian A
(2003). A prospective survey of patients with valvular heart disease in
Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 24,
1231-43.
Ix JH, Katz R, Peralta CA, De Boer IH, Allison MA, Bluemke DA, Siscovick DS,
Lima JA, Criqui MH (2010). A high ankle brachial index is associated with
greater left ventricular mass MESA (Multi-Ethnic Study of Atherosclerosis). J
Am Coll Cardiol 55, 342-9.
Jamshidi Y, Montgomery HE, Hense HW, Myerson SG, Torra IP, Staels B, World
MJ, Doering A, Erdmann J, Hengstenberg C, Humphries SE, Schunkert H,
Flavell DM (2002). Peroxisome proliferator--activated receptor alpha gene
regulates left ventricular growth in response to exercise and hypertension.
Circulation 105, 950-5.
Pagina 103 van 122